Samira
MiniMed Champion

MiniMed logo

MiniMed 780G insulin pump system

Life with diabetes just got easier


Experience the #1 pump in preventing highs and lows based on user satisfaction.1-3 Now even easier to use when paired with the new Instinct sensor, made by Abbott.

MiniMed Instinct sensor by Abbott

Small and discreet,4 the all-in-one sensor can be worn for up to 15 days.

Order now

Get more out of your diabetes management

Our system offers several features and benefits.

Time in Range pie chart

See how our insulin pump system works


  • Anticipates — Predicts where your glucose levels are headed and how much insulin you’ll need based on your real-time data and past trends.
  • Adjusts — Makes precise adjustments to insulin delivery to help keep you in range and protect from highs and lows.
  • Corrects — Automatically corrects highs to help for undercounted carbs or a missed meal dose.

Meet the system

Order the MiniMed™ 780G system now and get our latest CGM technology.


Submit the form below and our team will reach out to discuss the option that’s right for you. 

If you’re an existing customer, place your order on Diabetes.shop for quicker processing.



How can we communicate with you?


The MiniMed™ 780G system components


Get notified of highs and lows


Our mobile apps keep you in in the know!
Person holding phone with screen showing MiniMed Mobile app
MiniMed™ Mobile App

See insulin pump data and glucose levels on your smart device.


CareLink™ Connect App

Designed for care partners, remotely view the glucose levels and insulin pump information of a person with diabetes.


Apple® watch is a registered trademark of Apple Inc.

Reasons to choose an insulin pump


Benefits of insulin pump therapy include:

  • Fewer injections — With an insulin pump, you insert an infusion set every few days. Multiple daily injections often require several shots each day. An insulin pump holds up to 300 units of insulin and delivers it discreetly with a few button pushes.
  • Mealtime dosing — The bolus calculator eliminates complex math and tracks active insulin. Tracking active insulin can help avoid stacking and going low.
  • More stable blood sugar — The system automatically adjusts basal insulin delivery all day and night to help you achieve better glucose control with fewer highs and lows.
  • Individualized insulin delivery — An insulin pump delivers rapid-acting insulin and provides basal and bolus doses to better match your needs.

Footnotes
† Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
‡ Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Glucose targets should be chosen following a consultation with your healthcare provider.
◊ Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 3:00 AM- 6:00 AM. Number of users with ≥10 days of sensor glucose data; Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time.
¶ Refers to SmartGuard™ technology. Individual results may vary.

References
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed
2. Individual results may vary.
3. dQ&A US Patient Voice Q2 2025.p. 77. N=215
4. Data on file, Abbott Diabetes Care, Inc.​​
5. McVean, et al. 972-P: Hyperglycemia from Real-World Dawn Phenomenon Is Nearly Eliminated with the MiniMed 780G System (MM780G). Diabetes 14 June 2024; 73 (Supplement_1): 972–P. https://doi.org/10.2337/db24-972-P


Important Safety Information: MiniMed™ 780G system with SmartGuard™ technology with Instinct sensor, Simplera Sync™ sensor, and Guardian™ 4 sensor

The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older using the Instinct, Simplera Sync™ or Guardian™ 4 sensor, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin using the Simplera Sync™ or Guardian™ 4 sensor.

The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera Sync™ and Guardian™ 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes using the Instinct sensor, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.

© Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image © Abbott. ™*Third–party brands are trademarks of their respective owners.